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Abstract
Background—Gastroenterology specialty societies have advocated that providers routinely
assess their performance on colonoscopy quality measures. Such routine measurement has been
hampered by the costs and time required to manually review colonoscopy and pathology reports.
Natural Language Processing (NLP) is a field of computer science in which programs are trained
to extract relevant information from text reports in an automated fashion.
Objective—To demonstrate the efficiency and potential of NLP-based colonoscopy quality
measurement
Design—In a cross-sectional study design, we used a previously validated NLP program to
analyze colonoscopy reports and associated pathology notes. The resulting data were used to
generate provider performance on colonoscopy quality measures.
Setting—Nine hospitals in the UPMC health care system.
Patients—Study sample consisted of the 24,157 colonoscopy reports and associated pathology
reports from 2008-9
Main Outcome Measurements—Provider performance on seven quality measures
Results—Performance on the colonoscopy quality measures was generally poor and there was a
wide range of performance. For example, across hospitals, adequacy of preparation was noted
overall in only 45.7% of procedures (range 14.6% to 86.1% across nine hospitals), documentation
of cecal landmarks was noted in 62.7% of procedures (range 11.6% to 90.0%), and the adenoma
detection rate was 25.2% (range 14.9% to 33.9%).
Limitations—Our quality assessment was limited to a single health care system in Western
Pennsylvania
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Conclusions—Our study illustrates how NLP can mine free-text data in electronic records to
measure and report on the quality of care. Even within a single academic hospital system there is
considerable variation in the performance on colonoscopy quality measures, demonstrating the
need for better methods to regularly and efficiently assess quality.
Introduction
Colorectal cancer is the 2nd leading cause of cancer death in the US.1 Colorectal cancer is
preventable because removing adenomas, the precursors to colorectal cancer, can reduce
colorectal cancer incidence. Colonoscopy is a cost-effective and common method of
screening for colorectal cancer. 2,3 However, colonoscopy has shortfalls in screening,
because, among other reasons, physician miss adenomas during a colonoscopy.4-8 There is
great variation across physicians in the fraction of colonoscopies in which an adenoma is
found (in one study rates ranged from 9.4% to 32.7%).9 Further, a patient who has a
colonoscopy performed by a physician with a low adenoma detection rate is at increased risk
of developing subsequent colorectal cancer.10
There is also variation in other aspects of colonoscopy quality.8,11 For example, physician's
recommendations for follow-up colonoscopies are often shorter than guideline
recommendations.12-14 In a large fraction of colonoscopies, there is no indication provided
on the colonoscopy report or the indication listed is not on the list of recommended
indications. This overuse of colonoscopy decreases access to care, drives up health care
costs, and exposes patients to unnecessary risk.15 Access is important because there of a
shortage of colonoscopy capacity.16 These data demonstrate, as one editorialist believes the
“effectiveness of colonoscopy as a screening tool is a lot better (and worse) in some
endoscopists' hands than others.”5
This evidence has led gastroenterology specialty societies to call for physicians to regularly
monitor their performance on colonoscopy quality measures so care can be improved.17,18
Unfortunately, such routine measurement is not taking place, primarily due to the
inconvenience and expense.15 Measuring adenoma detection rates and other quality
measures typically requires manual review of colonoscopy and pathology reports. To
address the difficulty in measuring physician quality, we developed the first natural
language processing (NLP)-based computer software application (C-QUAL) for measuring
performance on colonoscopy quality indicators.19
Background
NLP is a field of computer science in which the computer is trained to “read” text to identify
relevant data.20 C-QUAL automatically analyzes both colonoscopy and pathology reports in
the electronic health record (EHR) and abstracts the necessary information (e.g. indication,
polyp detection, cecal intubation). It can thereby assess all the important aspects of
colonoscopy quality. We tested C-QUAL by comparing it to the gold standard of manual
abstraction by a physician and found that the C-QUAL tool had excellent accuracy on nine
different quality measures advocated by specialty societies.19
In this study, our objective was to demonstrate the efficiency and potential of NLP-based
colonoscopy quality measurement. To do so, we used C-QUAL to analyze almost 25
thousand reports in a large hospital system to to highlight performance variation across
hospitals and physicians.
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We conducted a cross-sectional analysis of reports from relevant colonoscopy procedures
over a two-year period in a single hospital system.
Development of Quality Measures
The American Society for Gastrointestinal Endoscopy/American College of
Gastroenterology17 and the U.S. Multi-Society Task Force on Colorectal Cancer18 have
published quality measures for colonoscopy. From these publications, we identified 20
potential measures. For each measure, we created detailed specifications on which
colonoscopy reports were eligible and which reports met criteria for passing [Appendix
describes process of identifying 20 measures and the specifications]. For example, one
published quality measure is notation and photo documentation of cecal landmarks. We
judged visualization of the cecal landmarks to be met if the report stated any of the
following, (1) appendiceal orifice or ileo-cecal valve (2) entering ileum, (3) any of the
following phrases “cecal landmarks”, “typical landmarks”, “landmarks of cecum”,
“characteristic anatomy”, (4) or noted that patient has a prior resection (e.g. “ileocolonic
anastomosies”). If the report included negation of relevant phrases (e.g. “cecal landmarks
not visualized”, we did not count this as visualization of cecal landmarks. Based on
published quality measures for this measure,17 we excluded from the denominator reports
where the preparation was inadequate and where the procedure was aborted prematurely.
Development and Validation of NLP Tool
NLP is intended to take the place of a manual abstractor, automatically extracting key
information from colonoscopy reports and categorizing the information as passing or not
passing a given quality measure based on the specifications. Our NLP-based colonoscopy
measurement tool has three basic processing steps (1) parsing the text of the reports into
sentences, words, and sections, (2) identifying key concepts (e.g., gastrointestinal bleeding)
by matching the text against clinical vocabularies, and (3) understanding the meaning of key
concepts (e.g., is the gastrointestinal bleeding the indication for procedure or a
complication?) by examining their context in the report.
Details on the development and validation of our NLP-based colonoscopy measurement tool
are published elsewhere.19 Briefly, we used an iterative process to develop the tool.
Clinicians identified relevant information from randomly selected colonoscopy reports, and
these samples of manually abstracted data were used to formulate the rules for the NLP tool.
After this process was complete and the NLP tool was finalized, we tested its performance
by applying it to 453 new colonoscopy and associated pathology reports. We compared the
NLP tool's output against a manual evaluation of the same reports by a physician. We tested
both the accuracy of abstraction of specific data elements as well as quality measures. As
detailed in the Appendix, nine of the 20 measures showed high agreement (kappa > 0.7)
between the NLP tool and clinician abstraction. Of these nine measures, we report seven in
the manuscript. These quality measures are listed in Table 2 and each measure's
specifications are included in the Appendix. As detailed in the Appendix, we dropped two
measures (withdrawal time >6 minutes, fraction of colonoscopies where preparation
adequate) as they were redundant and highly correlated with two measures that were
retained (withdrawal time documented, fraction of colonoscopies where preparation
documented).
Dataset
Our data came from the UPMC Medical Archival System data repository,21 which includes
clinical data that comes directly from the electronic medical record of patients seen at
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UPMC's hospitals and physician offices. We limited our analyses to reports from 2008-9 at
the nine UPMC hospitals where colonoscopies are performed, which are not children's
hospitals, and where pathology reports are available. Some UPMC hospitals are still in a
transition stage of interfacing transcription data into the database and all reports were not
available for analysis. The data repository permits longitudinal profiles of patient events to
be created with direct links to all the elements of the clinical electronic record. All records
were de-identified using the De-ID program.22
Applying NLP Tool to Sample of Colonoscopy Reports
After identifying all colonoscopy and associated pathology reports, we excluded reports
where (1) there was more than one endoscopic procedure (e.g. upper endoscopy and
colonoscopy) and/or pathology report on the same day; (2) the same report described a
combined upper endoscopy and colonoscopy procedure; (3) the patient identifier was
missing and (4) the report was generated via ProVation software. ProVation software allows
a clinician to generate a colonoscopy report with pre-populated drop-down menus. Because
the reports are already generated in a structured format, we did not apply the NLP tool to
these reports. We did include reports generated by Pentax software (14% of all colonoscopy
reports in our sample), in which the physician is prompted to input free text to fill in
template sentences and to record additional information. These Pentax reports represent a
combination of free text and structured sentences. The remaining colonoscopy reports in our
study sample were dictated and transcribed (86% of reports).
After applying the NLP tool to the reports, we linked the reports to information on the
patient, the physician who performed the procedure, and the hospital where it was
performed. For some physicians we had access to only the subset of the colonoscopies they
performed at UPMC hospitals. These physicians are in private practice and performed
procedures at UPMC hospitals, non-UPMC hospitals, and unaffiliated private endoscopy
centers.
Statistical Analysis
We report the overall performance for each quality measure by hospital and by physician.
We restricted our analyses on variation in physician performance to physicians with at least
30 reports in our dataset; 30 is a cut off used in prior work.10 To assess the face validity of
the data reported by the NLP tool, we assessed the adenoma detection rate by selected
patient characteristics known to be associated with higher risk of adenomas.14,23-25 All
statistical analyses were conducted using SAS (Version 9.2, SAS Institute, Cary, NC, 2010).
Approval for this study was obtained from both the University of Pittsburgh and RAND
Human Subjects Protection Committees.
Results
A total of 24,157 reports were analyzed using the NLP tool. Of all colonoscopies, 54.1%
were performed on females and the majority of patients (59.0%) were between 50-69 years
of age.[Table 1] All 9 hospitals were in urban areas and four were members of the Council
of Teaching Hospitals. The number of admissions per year at the hospitals varied from 5000
to <10,000 (n=2, 22.2%), 10,000 to <20,000 (n=5, 55.6%), and ≥20,000 (n=2, 22.2%)
(Appendix Table 5). The specialty of the 77 physicians with 30 or more cases was
gastroenterology/internal medicine (n=60, 77.9%) or general/colorectal surgery (n=17,
22.1%). Twenty-four (31.2%) had primary teaching appointments at the University of
Pittsburgh School of Medicine (Appendix Table 6).
Mehrotra et al. Page 4













Analysis of the data generated by our NLP tool revealed that performance on most quality
measures was poor, with a wide range of performance across hospitals and physicians
(Table 2, Figure 1, Appendix Table 6). American Society of Anesthesiologists (ASA)
classification for fitness for surgery was reported in 7.2% of reports (range 0% to 39.8%
across 9 hospitals), informed consent for procedure was noted in 50.0% (range 2.1% to
98.3%), preparation of colon was recorded in 45.7% (range 14.6% to 86.1%), cecal
landmarks in 62.7% (range 11.6% to 90.0%), withdrawal time was recorded in 1.5% (range
0% to 5.6%), and a biopsy was obtained for patients with chronic diarrhea in 79.7% (range
73.3% to 95.7%). One or more adenomas were detected in 25.2% of colonoscopies (range
across hospitals 14.9% to 33.9%).
On six of the seven quality measures, colonoscopy reports using the structured report system
had a higher quality score than dictated reports (Figure 2). For example, quality of
preparation was noted in 90.3% of reports generated by the stuctured report system and
36.4% of dictated reports (p<0.001 for test of comparison). Only with adenoma detection
rate was there lower performance among reports generated by the stuctured reports systems
vs. dictation (21.9% vs. 25.9% respectively, p<0.001).
Several patient and physician factors were associated with differential adenoma detection
rates (Appendix Table 8). For example, adenoma detection rates were higher among male
vs. female patients (31.0% vs. 20.3%, p<0.001) and older patients (e.g. >80 yo patients
(31.3%) vs. 40-49 yo (16.7%)). Colonoscopies performed by gastroenterologists had higher
adenoma detection rates than those performed by general surgeons (25.6% vs. 20.5%,
p<0.001).
Discussion
Our results highlight the potential of NLP to measure performance on colonoscopy quality
measures. Our NLP tool efficiently analyzed a large sample of colonoscopy reports. Our
findings demonstrate there is clear variation in performance, even within a highly-regarded
academic healthcare system. Across the nine hospitals, there was almost three-fold variation
in the adenoma detection rate. The variation in performance on the quality measures across
physicians was even larger.
Prior work has identified this variation in quality as one of the limitations of colonoscopy as
a screening tool for colorectal cancer screening.5 Specialty societies and experts have called
for providers to routinely report on their colonoscopy performance,5 but few physicians are
reporting their quality.11,26 NLP could be one means of making routine reporting more
common.
Our results highlight several advantages and disadvantages of using NLP for routine quality
measurement using data in EHRs. The key advantage of NLP is that it is economically
feasible. It would be prohibitively expensive and time consuming to manually review tens of
thousands of colonoscopy reports. Another advantage is that NLP allows providers to
continue to use natural narrative when describing patient care. There has been criticism that
structured note systems in current EHRs force providers to create unnatural and overly
structured notes27 which take extra time to create28,29 and impede communication because
these notes are difficult to read.29 The NLP tool also has the advantage is that it can be
easily adapted over time to incorporate changes to the quality measures.
There are also disadvantages of NLP-based quality measurement. As we document in the
Appendix, the accuracy of the tool compared to physician abstraction decreased as the
complexity of the data and language increased (e.g. indication for procedure). We focused
on colonoscopy reports which are relatively limited in scope and length. NLP-based tools
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will have more difficulty with documents such as outpatient notes or discharge summaries.
For high-stakes applications such as public reporting of quality or pay-for-performance
tools, providers may not accept the level of accuracy currently achieved by our NLP tool.
However, we note that we are working to refine the NLP program to improve its
performance and that the alternatives to NLP also have limitations. Data manually abstracted
from medical records frequently contain errors28,30 and claims data, another common source
of data for quality measures, may not always accurately reflect clinical care.31 Another issue
with our current tool is that we only focus on the text within the colonoscopy and pathology
notes. Important information could be included elsewhere. For example, the indication for
the procedure might be on a progress note and the withdrawal time could be calculated by
comparing the time stamps on the photographs of the appendiceal orifice and retroflexion in
the rectum (if such photos were included).
Instead of dictations, some physicians are using software (e.g., CORI, gMed, ProVation)
with pull-down menus to create colonoscopy reports. These report tools facilitate quality
measurement and some might be concerned that these software programs preclude the need
for a NLP tool. We believe our NLP tool still has advantages. To generate adenoma
detection rates using such software, one must still manually abstract pathology reports. Also,
within and across endoscopy centers, physicians might use different software tools and/or
dictation. C-QUAL can analyze any type of report.
In our analyses, reports generated by software tools had higher performance on
documentation-specific measures (e.g., indicating informed consent), but there was no
difference in performance for adenoma detection rates. There was also no clear correlation
across hospitals between documentation-specific measures and adenoma detection rates. For
example, the hospital with the highest adenoma detection rate had the lowest performance
on reporting bowel preparation and withdrawal time. These findings highlight a larger
debate regarding the focus on quality measurement. From a clinical perspective,
colonoscopy quality measures that reflect documentation may be seen as less important than
measures of outcomes such as adenoma detection rate.32 In other words, devoting resources
to software that improves the completeness of documentation may not necessarily lead to
better clinical outcomes.
Consistent with prior studies,14,23-25 we find that the adenoma detection rate is higher
among males and older patients. This consistency with the prior literature increases the face
validity of the NLP tool. Though there is great variation in the adenoma detection rate across
providers in our sample, the overall adenoma detection rate observed in our study population
exceeds the recommended benchmarks for the adenoma detection rate (≥25% for men over
50, ≥15% for women over 50) published in quality guidelines.17
Our study has several limitations. Because it is limited to a single hospital system and there
is variation in the manner physicians record colonoscopy reports, it is likely that our NLP
tool would need to be adapted to the reporting style and language used by other physicians
to achieve comparable performance in another setting. Consistent with prior studies, we did
not adjust provider scores for differences in patient population. This type of risk adjustment
will have to be considered, especially if one begins profiling physicians who sub-specialize
and who treat patients with clearly different adenoma detection rates (e.g. patients with
inflammatory bowel disease or younger patients).
In summary, our analyses highlight the potential for NLP to evaluate performance on
colonoscopy quality measures in an inexpensive and automated fashion. This type of routine
quality meaurement can be the foundation for efforts to improve colonoscopy quality.
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Figure 1. Performance on Quality Indicators for 9 Individual Hospitals and 77 Physicians with
≥30 Reports*
*Heavy vertical line indicates median performance and the surrounding box represents the
boundaries of the 25th and 75th percentile of performance. The extended horizontal line
(“whisker”) extends one and a half times the interquartile range beyond the box. The
individual circles mark the performance of providers whose performance is outside the
boundaries of the box (i.e. the 25th and 75th percentile).
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Figure 2. Performance on Quality Indicators Based on How Colonoscopy Report Was Created*
*Difference between two types of methods of generating reports statistically significant at
p<0.001 level for 6 of the 7 quality measures. For difference on withdrawal time, p-value
0.02
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Table 1
Patient and Provider Characteristics of 24,157 Colonoscopy Reports#
Characteristic Value
Sex - no. (%)*
 Female 13,038 (54.1)
 Male 11,063 (45.9)
Age group - no. (%)
 ≤18 yr 14 (0.1)
 19-29 yr 669 (2.8)
 30-39 yr 1,067 (4.4)
 40-49 yr 2,717 (11.2)
 50-59 yr 8,375 (34.7)
 60-69 yr 5,884 (24.4)
 70-79 yr 3,690 (15.3)
 ≥80 yr 1,741 (7.2)
Race - no. (%)
 White 20,532 (85.2)
 Black 2,195 (9.1)
 Other 1,430 (5.9)
Insurance - no. (%)
 Medicare 6,262 (26.0)
 Private 16,290 (67.6)
 Medicaid 1,002 (4.2)
 Other 603 (2.5)
Faculty status of physician performing procedure - no. (%)*
 Primary teaching appointment 4,434 (18.4)
 Other 19,519 (81.0)
Specialty of physician performing procedure - no. (%)*
 Gastroenterology or internal medicine 22,104 (91.7)
 General surgery or colorectal surgery 1,849 (7.7)
*
For 56 reports sex not recorded. For 204 reports, physician name not recorded or faculty status or specialty not available. Typically faculty status
and specialty is not recorded for trainees.
#
Totals may not equal 100% because of rounding
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